Trademark: 97532992
Word
IZURMI
Status
Registered
Status Code
700
Status Date
Tuesday, September 12, 2023
Serial Number
97532992
Registration Number
7162936
Registration Date
Tuesday, September 12, 2023
Mark Type
4000
Filing Date
Wednesday, August 3, 2022
Published for Opposition
Tuesday, June 27, 2023

Trademark Owner History
Glaxo Group Limited - Original Registrant

Classifications
5 Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders

Trademark Events
Sep 12, 2023
Notice Of Registration Confirmation Emailed
Sep 12, 2023
Registered-Principal Register
Jul 12, 2023
Teas Change Of Correspondence Received
Jul 12, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Jul 12, 2023
Teas Change Of Owner Address Received
Jun 27, 2023
Official Gazette Publication Confirmation E-Mailed
Jun 27, 2023
Published For Opposition
Jun 7, 2023
Notification Of Notice Of Publication E-Mailed
May 18, 2023
Approved For Pub - Principal Register
May 16, 2023
Assigned To Examiner
Aug 24, 2022
New Application Office Supplied Data Entered
Aug 6, 2022
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24